Status:
COMPLETED
Demonstration of the "SPECT/CT System With CZT Detectors" Imaging Performance in a Clinical Setting
Lead Sponsor:
GE Healthcare
Conditions:
Cancer
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
The primary purpose of the study is to obtain sample clinical images that are evaluated by physicians in support of regulatory submissions. Additionally, the study will provide data for current and fu...
Eligibility Criteria
Inclusion
- are 18-years old and older;
- is able to sign and date the informed consent form; AND
- have been prescribed by a physician a nuclear medicine exam that is within the intended use of the device.
Exclusion
- Patients who were referred for dynamic nuclear medicine scan because of the need to be injected twice (once for the conventional acquisition and once for the investigational device) that would result in an increase dose burden on patient.
- Pregnant or lactating women
- Who were previously enrolled in this study;
- Who have contraindication for the radiopharmaceutical
- Who have any conditions that, in the opinion of the Investigator, would interfere with the evaluation of the results or constitute a health hazard for the subject;
Key Trial Info
Start Date :
September 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2016
Estimated Enrollment :
19 Patients enrolled
Trial Details
Trial ID
NCT03229772
Start Date
September 1 2015
End Date
May 1 2016
Last Update
July 26 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rambam Health Care Center
Haifa, Israel, 3109601